Lupus Landmark Study: A Prospective Registry and Biorepository
Sponsored by Lupus Research Alliance
About this study
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
This is a multicenter registry and biorepository conducted in the United States (US) and Canada. The registry will enroll over 3500 individuals with SLE over the course of five years into one of following four cohorts: * New Onset: individuals with a new diagnosis of SLE * Active Lupus Nephritis: individuals with a recent diagnosis of LN * Extra-Renal Lupus Flare: individuals who have experienced a recent flare * Prevalent Cases: individuals with lupus who do not meet the criteria for one of the other cohorts The registry data will include but is not limited to: patient demographics, medical history, clinician-reported outcomes (ClinROs), patient-reported outcomes (PROs), social history and determinants of health, and environmental exposures. Participants will also be asked to allow acce…
Where this study is enrolling (19)
- I'm interested
University of Alabama at Birmingham
Birmingham, Alabama
- I'm interested
University of Arizona
Tucson, Arizona
- I'm interested
UCLA
Los Angeles, California
- I'm interested
Wallace Rheumatic Studies Center
Beverly Hills, California
- I'm interested
Georgetown University
Washington D.C., District of Columbia
Show all 19 locations
- I'm interested
University of Miami
Miami, Florida
- I'm interested
Emory University
Atlanta, Georgia
- I'm interested
University of Chicago
Chicago, Illinois
- I'm interested
Brigham and Women's Hospital
Boston, Massachusetts
- I'm interested
University of Massachusetts Memorial Health
Worcester, Massachusetts
- I'm interested
Washington University
St Louis, Missouri
- I'm interested
Northwell Health
New York, New York
- I'm interested
Columbia University Medical Center
New York, New York
- I'm interested
The Feinstein Institutes for Medical Research
Manhasset, New York
- I'm interested
SUNY Upstate
Syracuse, New York
- I'm interested
UNC Chapel Hill
Chapel Hill, North Carolina
- I'm interested
The MetroHealth System
Cleveland, Ohio
- I'm interested
Vanderbilt University Medical Center
Nashville, Tennessee
- I'm interested
UT Southwestern Medical Center
Dallas, Texas
Who can participate
Inclusion criteria
- ✓Able to understand and comply with study procedures and voluntarily sign a written informed consent document
- ✓Age 18 years or older at the time of enrollment
- ✓Fulfill criteria for SLE based on one or more of the following classifications systems:
- ✓Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment.
Exclusion criteria
- ✕Not able to obtain consent
- ✕Not able to meet protocol visit requirements
- ✕Pregnant at the time of enrollment
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.